IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-38682-4.html
   My bibliography  Save this article

Persistent serum protein signatures define an inflammatory subcategory of long COVID

Author

Listed:
  • Aarthi Talla

    (Allen Institute for Immunology)

  • Suhas V. Vasaikar

    (Allen Institute for Immunology
    Seagen)

  • Gregory Lee Szeto

    (Allen Institute for Immunology
    Seagen)

  • Maria P. Lemos

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Julie L. Czartoski

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Hugh MacMillan

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Zoe Moodie

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Kristen W. Cohen

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center
    Moderna)

  • Lamar B. Fleming

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Zachary Thomson

    (Allen Institute for Immunology)

  • Lauren Okada

    (Allen Institute for Immunology)

  • Lynne A. Becker

    (Allen Institute for Immunology)

  • Ernest M. Coffey

    (Allen Institute for Immunology)

  • Stephen C. Rosa

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Evan W. Newell

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Peter J. Skene

    (Allen Institute for Immunology)

  • Xiaojun Li

    (Allen Institute for Immunology)

  • Thomas F. Bumol

    (Allen Institute for Immunology)

  • M. Juliana McElrath

    (Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)

  • Troy R. Torgerson

    (Allen Institute for Immunology)

Abstract

Long COVID or post-acute sequelae of SARS-CoV-2 (PASC) is a clinical syndrome featuring diverse symptoms that can persist for months following acute SARS-CoV-2 infection. The aetiologies may include persistent inflammation, unresolved tissue damage or delayed clearance of viral protein or RNA, but the biological differences they represent are not fully understood. Here we evaluate the serum proteome in samples, longitudinally collected from 55 PASC individuals with symptoms lasting ≥60 days after onset of acute infection, in comparison to samples from symptomatically recovered SARS-CoV-2 infected and uninfected individuals. Our analysis indicates heterogeneity in PASC and identified subsets with distinct signatures of persistent inflammation. Type II interferon signaling and canonical NF-κB signaling (particularly associated with TNF), appear to be the most differentially enriched signaling pathways, distinguishing a group of patients characterized also by a persistent neutrophil activation signature. These findings help to clarify biological diversity within PASC, identify participants with molecular evidence of persistent inflammation, and highlight dominant pathways that may have diagnostic or therapeutic relevance, including a protein panel that we propose as having diagnostic utility for differentiating inflammatory and non-inflammatory PASC.

Suggested Citation

  • Aarthi Talla & Suhas V. Vasaikar & Gregory Lee Szeto & Maria P. Lemos & Julie L. Czartoski & Hugh MacMillan & Zoe Moodie & Kristen W. Cohen & Lamar B. Fleming & Zachary Thomson & Lauren Okada & Lynne , 2023. "Persistent serum protein signatures define an inflammatory subcategory of long COVID," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-38682-4
    DOI: 10.1038/s41467-023-38682-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-38682-4
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-38682-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Yan Xie & Benjamin Bowe & Ziyad Al-Aly, 2021. "Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ivan Chun Hang Lam & Ran Zhang & Kenneth Keng Cheung Man & Carlos King Ho Wong & Celine Sze Ling Chui & Francisco Tsz Tsun Lai & Xue Li & Esther Wai Yin Chan & Chak Sing Lau & Ian Chi Kei Wong & Eric , 2024. "Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    2. Evan Xu & Yan Xie & Ziyad Al-Aly, 2023. "Long-term gastrointestinal outcomes of COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    3. Chengxi Zang & Yongkang Zhang & Jie Xu & Jiang Bian & Dmitry Morozyuk & Edward J. Schenck & Dhruv Khullar & Anna S. Nordvig & Elizabeth A. Shenkman & Russell L. Rothman & Jason P. Block & Kristin Lyma, 2023. "Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    4. Rúbens Prince dos Santos Alves & Julia Timis & Robyn Miller & Kristen Valentine & Paolla Beatriz Almeida Pinto & Andrew Gonzalez & Jose Angel Regla-Nava & Erin Maule & Michael N. Nguyen & Norazizah Sh, 2024. "Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice," Nature Communications, Nature, vol. 15(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-38682-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.